Abnormalities in a type of brain cell called astrocytes may play a pivotal role in causing some behavioral symptoms of autism spectrum disorders, according to a preclinical study by Weill Cornell Medicine investigators.
New evidence from a zebrafish model of epilepsy may help resolve a debate into how seizures originate, according to Weill Cornell Medicine and NewYork-Presbyterian investigators. The findings may also be useful in the discovery and development of future epilepsy drugs.
The center, with more than 120 faculty members, builds on the multidisciplinary nature of research into the immune system, with links between infection biology, vaccine development, genetics, genomics, malignancy and biomedical engineering.
Inhibiting an important signaling pathway in brain-resident immune cells may calm brain inflammation and thereby slow the disease process in Alzheimer’s and some other neurodegenerative diseases, a study by Weill Cornell Medicine investigators suggests.
Hysteroscopic sterilization, a nonincisional procedure, was found to be as effective as minimally invasive laparoscopic sterilization in preventing pregnancy, but both methods had higher-than-expected failure rates, according to a new study led by an investigator at Weill Cornell Medicine.
New cancer cell research opens a new avenue for understanding how tumors spread to other tissues via metastasis, and hints at novel ways to block the spread of cancer by targeting the process.
Three distinguished Weill Cornell Medicine physician-scientists, Dr. Joseph J. Fins, Dr. Rainu Kaushal and Dr. Shahin Rafii, have been elected to the Association of American Physicians.
Among participants who had hepatitis C and who injected drugs, those treated at a non-stigmatizing “accessible care” treatment center co-located with a syringe service program were nearly three times more likely to be cured, according to new research.
